02575.HK
Xuanzhubio-b
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 8.60
+0.64%Margins
Gross margin
34.4%
EBITDA margin
-158.8%
EBIT margin
-182.2%
Net margin
-200.8%
FCF margin
-183.4%
-15.7%
Return on equity
-13.1%
Return on assets
-14.2%
Return on invested capital
0.07x
Asset turnover
-HKD 213.6M
Cash from operations
HKD 1.30
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026